Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipids in type 2 diabetes.

Markku Laakso1

  • 1Department of Medicine, University of Kuopio, Kuopio, Finland. markku.laakso@kuh.fi

Seminars in Vascular Medicine
|October 14, 2005
PubMed
Summary
This summary is machine-generated.

Type 2 diabetes significantly raises cardiovascular disease risk. Managing lipid abnormalities like high triglycerides and low HDL cholesterol with statins and fibrates is crucial for prevention in diabetic patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial genome copy number measured by DNA sequencing in human blood is strongly associated with metabolic traits via cell-type composition differences.

Human genomics·2021
Same author

The trans-ancestral genomic architecture of glycemic traits.

Nature genetics·2021
Same author

Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies.

Nature communications·2021
Same author

Association of structural variation with cardiometabolic traits in Finns.

American journal of human genetics·2021
Same author

Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals.

Nature genetics·2021
Same author

n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies.

Diabetes care·2021
Same journal

Fibrin D-dimer and cardiovascular risk.

Seminars in vascular medicine·2005
Same journal

D-dimer testing in ischemic stroke and cerebral sinus and venous thrombosis.

Seminars in vascular medicine·2005
Same journal

D-dimer testing in pregnancy.

Seminars in vascular medicine·2005
Same journal

D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.

Seminars in vascular medicine·2005
Same journal

D-dimer, oral anticoagulation, and venous thromboembolism recurrence.

Seminars in vascular medicine·2005
Same journal

Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools.

Seminars in vascular medicine·2005
See all related articles

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Type 2 diabetes (T2D) is linked to a 2-4 fold increased risk of cardiovascular disease (CVD).
  • The exact mechanisms behind this elevated CVD risk in T2D patients remain unclear despite associated risk factor clustering.
  • Key lipid abnormalities in T2D include elevated triglycerides and reduced high-density lipoprotein (HDL) cholesterol.

Purpose of the Study:

  • To investigate the relationship between lipid profiles and cardiovascular disease risk in type 2 diabetes.
  • To evaluate the effectiveness of lipid-lowering therapies in preventing cardiovascular events in diabetic individuals.

Main Methods:

  • Analysis of prospective population-based studies on cardiovascular risk factors.
  • Review of recent drug treatment trials involving statins and fibrates.

Related Experiment Videos

Main Results:

  • Total cholesterol is a risk factor for coronary heart disease (CHD) in T2D patients, similar to non-diabetics.
  • High triglycerides and low HDL cholesterol may pose a greater CHD risk in T2D patients.
  • Statins and fibrates demonstrate significant benefits in preventing CVD in diabetic patients, comparable to non-diabetic populations.

Conclusions:

  • Lipid and lipoprotein abnormalities are significant contributors to the excess cardiovascular risk in type 2 diabetes.
  • Targeting lipid profiles through statin and fibrate therapy is an effective strategy for cardiovascular disease prevention in T2D.
  • Further research into the specific mechanisms driving CVD in T2D is warranted.